Megan Landes1,2, Monique van Lettow1,3, Joep J van Oosterhout1,4,5, Erik Schouten6, Andrew Auld7, Thokozani Kalua8, Andreas Jahn8,9, Beth A Tippett Barr10. 1. Dignitas International, Zomba, Malawi. 2. Department of Family and Community Medicine, University of Toronto, Toronto, Canada. 3. Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. 4. Partners in Hope, Lilongwe, Malawi. 5. David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. 6. Management Sciences for Health, Lilongwe, Malawi. 7. Centers for Disease Control and Prevention, Lilongwe, Malawi. 8. Ministry of Health, Lilongwe, Malawi. 9. I-TECH, Department of Global Health, University of Washington, Seattle, Washington, United States of America. 10. Centers for Disease Control and Prevention, Kisumu, Kenya.
Abstract
BACKGROUND: Long-term viral load (VL) suppression among HIV-positive, reproductive-aged women on ART is key to eliminating mother-to-child transmission (MTCT) but few data exist from sub-Saharan Africa. We report trends in post-partum VL in Malawian women on ART and factors associated with detectable VL up to 24 months post-partum. METHODS: 1-6 months post-partum mothers, screened HIV-positive at outpatient clinics in Malawi, were enrolled (2014-2016) with their infants. At enrollment, 12- and 24-months post-partum socio-demographic and PMTCT indicators were collected. Venous samples were collected for determination of maternal VL (limit of detection 40 copies/ml). Results were returned to clinics for routine management. RESULTS: 596/1281 (46.5%) women were retained in the study to 24 months. Those retained were older (p<0.01), had higher parity (p = 0.03) and more likely to have undetectable VL at enrollment than those lost to follow-up (80.0% vs 70.2%, p<0.01). Of 590 women on ART (median 30.1 months; inter-quartile range 26.8-61.3), 442 (74.9%) with complete VL data at 3 visits were included in further analysis. Prevalence of detectable VL at 12 and 24 months was higher among women with detectable VL at enrollment than among those with undetectable VL (74 detectable VL results/66 women vs. 19/359; p<0.001). In multivariable analysis (adjusted for age, parity, education, partner disclosure, timing of ART start and self-reported adherence), detectable VL at 24 months was 9 times more likely among women with 1 prior detectable VL (aOR 9.0; 95%CI 3.5-23.0, p<0.001) and 226 times more likely for women with 2 prior detectable VLs (aOR 226.4; 95%CI 73.0-701.8, p<0.001). CONCLUSIONS: Detectable virus early post-partum strongly increases risk of ongoing post-partum viremia. Due to high loss to follow-up, the true incidence of detectable VL over time is probably underestimated. These findings have implications for MTCT, as well as for the mothers, and call for intensified VL monitoring and targeted adherence support for women during pregnancy and post-partum.
BACKGROUND: Long-term viral load (VL) suppression among HIV-positive, reproductive-aged women on ART is key to eliminating mother-to-child transmission (MTCT) but few data exist from sub-Saharan Africa. We report trends in post-partum VL in Malawian women on ART and factors associated with detectable VL up to 24 months post-partum. METHODS: 1-6 months post-partum mothers, screened HIV-positive at outpatient clinics in Malawi, were enrolled (2014-2016) with their infants. At enrollment, 12- and 24-months post-partum socio-demographic and PMTCT indicators were collected. Venous samples were collected for determination of maternal VL (limit of detection 40 copies/ml). Results were returned to clinics for routine management. RESULTS: 596/1281 (46.5%) women were retained in the study to 24 months. Those retained were older (p<0.01), had higher parity (p = 0.03) and more likely to have undetectable VL at enrollment than those lost to follow-up (80.0% vs 70.2%, p<0.01). Of 590 women on ART (median 30.1 months; inter-quartile range 26.8-61.3), 442 (74.9%) with complete VL data at 3 visits were included in further analysis. Prevalence of detectable VL at 12 and 24 months was higher among women with detectable VL at enrollment than among those with undetectable VL (74 detectable VL results/66 women vs. 19/359; p<0.001). In multivariable analysis (adjusted for age, parity, education, partner disclosure, timing of ART start and self-reported adherence), detectable VL at 24 months was 9 times more likely among women with 1 prior detectable VL (aOR 9.0; 95%CI 3.5-23.0, p<0.001) and 226 times more likely for women with 2 prior detectable VLs (aOR 226.4; 95%CI 73.0-701.8, p<0.001). CONCLUSIONS: Detectable virus early post-partum strongly increases risk of ongoing post-partum viremia. Due to high loss to follow-up, the true incidence of detectable VL over time is probably underestimated. These findings have implications for MTCT, as well as for the mothers, and call for intensified VL monitoring and targeted adherence support for women during pregnancy and post-partum.
Authors: L Myer; T K Phillips; J A McIntyre; N-Y Hsiao; G Petro; A Zerbe; J Ramjith; L-G Bekker; E J Abrams Journal: HIV Med Date: 2016-06-28 Impact factor: 3.180
Authors: Tamsin Phillips; Kirsty Brittain; Claude A Mellins; Allison Zerbe; Robert H Remien; Elaine J Abrams; Landon Myer; Ira B Wilson Journal: AIDS Behav Date: 2017-02
Authors: Beth A Tippett Barr; Monique van Lettow; Joep J van Oosterhout; Megan Landes; Ray W Shiraishi; Ermias Amene; Erik Schouten; Nellie Wadonda-Kabondo; Sundeep Gupta; Andrew F Auld; Thokozani Kalua; Andreas Jahn Journal: Lancet HIV Date: 2018-11-19 Impact factor: 12.767
Authors: Matilda Ngarina; Charles Kilewo; Katarina Karlsson; Said Aboud; Annika Karlsson; Gaetano Marrone; Germana Leyna; Anna Mia Ekström; Gunnel Biberfeld Journal: BMC Infect Dis Date: 2015-04-08 Impact factor: 3.090
Authors: Megan Landes; Monique van Lettow; Ernest Nkhoma; Beth Tippett Barr; Zinenani Truwah; Erik Shouten; Andreas Jahn; Andrew Auld; Thokozani Kalua; Joep J van Oosterhout Journal: J Int AIDS Soc Date: 2019-06 Impact factor: 5.396
Authors: John M Humphrey; Julia Songok; Susan Ofner; Beverly Musick; Marsha Alera; Bett Kipchumba; Megan S McHenry; James G Carlucci; Jun Park; Winfred Mwangi; Constantin Yiannoutsos; Giorgos Bakoyannis; Kara Wools-Kaloustian Journal: AIDS Behav Date: 2022-04-25